Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.
D000818:Animals; D000906:Antibodies; D000970:Antineoplastic Agents / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D003520:Cyclophosphamide / Q000494:pharmacology; D005461:Fluorine; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007659:Ketones / Q000494:pharmacology; D008558:Melphalan / Q000494:pharmacology; D009578:Nitrobenzenes; D010047:Ovalbumin; D010879:Piperazines / Q000494:pharmacology; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D007659:Ketones; D009578:Nitrobenzenes; D010879:Piperazines; D005461:Fluorine; D003520:Cyclophosphamide; D010047:Ovalbumin; D001379:Azathioprine; D008558:Melphalan